Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Share repurchases by Quarter
Share repurchases — Cash paid for repurchases of common stock ($M) ($M)
Vertex Pharmaceuticals Share repurchases: $470M in Q2 2026, up 19.8% from a year earlier.
Where the Q2 2026 figure comes from
Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Consolidated Statements of Cash Flows & Item 2(c) / Item 5.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up share repurchases
- Share repurchases — Aggregate repurchase value under repurchase programs ($M)458 · Q2 2026
- Share repurchases — Shares repurchased under repurchase programs (M shares)1.10 · Q2 2026
- Item 2(c) / Item 5 Share Repurchases — Total shares purchased in quarter (thousands)1,033.70 · Q2 2026
- Monthly Share Repurchases (Item 2(c) / Item 5) — Total shares purchased in month (thousands)–
- Employee tax withholding — Cash paid for shares withheld on equity vesting ($M)4.30 · Q2 2026
- Common stock — Stockholders of record (holders)–
Cite this data
StockData. (2026). Vertex Pharmaceuticals Share repurchases ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/buyback-cash-tot
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.